E., cytokine storm) provoked by COVID-19 and other disorders. In the development of MesenCure, Bonus BioGroup applied a number of unique technologies and proprietary awareness, a few of which can be now in progress by the business, plus some of that are Component of the Company's wide mental home portfolio. https://bonusbahsi.com/